Dunfa Peng

3.4k total citations
87 papers, 2.6k citations indexed

About

Dunfa Peng is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Dunfa Peng has authored 87 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 30 papers in Surgery and 28 papers in Oncology. Recurrent topics in Dunfa Peng's work include Epigenetics and DNA Methylation (18 papers), Cancer-related gene regulation (17 papers) and Helicobacter pylori-related gastroenterology studies (14 papers). Dunfa Peng is often cited by papers focused on Epigenetics and DNA Methylation (18 papers), Cancer-related gene regulation (17 papers) and Helicobacter pylori-related gastroenterology studies (14 papers). Dunfa Peng collaborates with scholars based in United States, China and Japan. Dunfa Peng's co-authors include Wael El‐Rifai, Mohammed Soutto, Abbes Belkhiri, Zheng Chen, M. Kay Washington, Alexander Zaika, Shoumin Zhu, M. Blanca Piazuelo, Heng Lu and Vikas Sehdev and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Gastroenterology.

In The Last Decade

Dunfa Peng

85 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dunfa Peng United States 32 1.7k 689 657 627 491 87 2.6k
Zhi‐Feng Miao China 30 1.4k 0.8× 682 1.0× 796 1.2× 450 0.7× 436 0.9× 81 2.5k
Yanru Qin China 30 1.9k 1.1× 689 1.0× 1.1k 1.6× 416 0.7× 454 0.9× 98 2.7k
Nelson S. Yee United States 30 1.2k 0.7× 780 1.1× 354 0.5× 481 0.8× 308 0.6× 83 3.0k
Akiko Kokubu Japan 25 2.2k 1.3× 649 0.9× 594 0.9× 375 0.6× 404 0.8× 29 3.0k
Lidong Wang China 30 1.6k 0.9× 783 1.1× 589 0.9× 934 1.5× 497 1.0× 113 2.8k
I‐Ching Wang United States 27 2.7k 1.6× 518 0.8× 494 0.8× 439 0.7× 446 0.9× 44 3.4k
Shigetoyo Saji Japan 29 1.0k 0.6× 1.1k 1.6× 480 0.7× 573 0.9× 475 1.0× 173 2.8k
Lizong Shen China 26 1.0k 0.6× 670 1.0× 471 0.7× 429 0.7× 415 0.8× 52 1.9k
Eiji Kashiwagi Japan 31 1.3k 0.7× 628 0.9× 588 0.9× 565 0.9× 943 1.9× 126 2.6k
Yanglin Pan China 29 2.2k 1.3× 829 1.2× 1.2k 1.9× 397 0.6× 406 0.8× 78 3.1k

Countries citing papers authored by Dunfa Peng

Since Specialization
Citations

This map shows the geographic impact of Dunfa Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dunfa Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dunfa Peng more than expected).

Fields of papers citing papers by Dunfa Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dunfa Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dunfa Peng. The network helps show where Dunfa Peng may publish in the future.

Co-authorship network of co-authors of Dunfa Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Dunfa Peng. A scholar is included among the top collaborators of Dunfa Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dunfa Peng. Dunfa Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Jialun, et al.. (2025). WEE1 inhibition in cancer therapy: Mechanisms, synergies, preclinical insights, and clinical trials. Critical Reviews in Oncology/Hematology. 211. 104710–104710. 4 indexed citations
2.
Maacha, Selma, Dunfa Peng, Mohammed Soutto, et al.. (2024). SOX9 is regulated by AURKA in response to Helicobacter pylori infection via EIF4E-mediated cap-dependent translation. Cancer Letters. 593. 216939–216939. 4 indexed citations
3.
Ballout, Farah, Heng Lu, Nadeem S. Bhat, et al.. (2024). Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair. Clinical Cancer Research. 30(10). 2193–2205. 2 indexed citations
5.
Lu, Heng, Dunfa Peng, Mohammed Soutto, et al.. (2023). Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma. Molecular Therapy — Oncolytics. 30. 286–300. 2 indexed citations
6.
Lu, Heng, Farah Ballout, Abbes Belkhiri, et al.. (2023). Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma. Gut. 73(1). 47–62. 17 indexed citations
7.
Chen, Lei, Farah Ballout, Heng Lu, et al.. (2023). Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett’s Esophagus. Cancers. 15(19). 4821–4821. 5 indexed citations
8.
Chen, Lei, Heng Lu, Dunfa Peng, et al.. (2022). Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma. Gut. 72(3). 421–432. 19 indexed citations
9.
Zhu, Shoumin, Zheng Chen, Dunfa Peng, et al.. (2020). Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinib. Cancer Letters. 491. 87–96. 8 indexed citations
10.
Lu, Heng, Ajaz A. Bhat, Dunfa Peng, et al.. (2019). APE1 Upregulates MMP-14 via Redox-Sensitive ARF6-Mediated Recycling to Promote Cell Invasion of Esophageal Adenocarcinoma. Cancer Research. 79(17). 4426–4438. 20 indexed citations
11.
Zhu, Shoumin, Zheng Chen, Lihong Wang, et al.. (2018). A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers. Clinical Cancer Research. 24(8). 1905–1916. 14 indexed citations
12.
Chen, Zheng, Dunfa Peng, Mohammed Soutto, et al.. (2018). Methylation of the HOXA10 Promoter Directs miR-196b-5p–Dependent Cell Proliferation and Invasion of Gastric Cancer Cells. Molecular Cancer Research. 16(4). 696–706. 44 indexed citations
13.
Chen, Zheng, Shoumin Zhu, Jun Hong, et al.. (2015). Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis. Gut. 65(6). 925–934. 38 indexed citations
14.
Soutto, Mohammed, Dunfa Peng, Ahmed Katsha, et al.. (2014). Activation of β-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Gut. 64(7). 1028–1039. 75 indexed citations
15.
Sehdev, Vikas, Ahmed Katsha, Dunfa Peng, et al.. (2013). HDM2 Regulation by AURKA Promotes Cell Survival in Gastric Cancer. Clinical Cancer Research. 20(1). 76–86. 56 indexed citations
16.
Hong, Jun, Dunfa Peng, Zheng Chen, Vikas Sehdev, & Abbes Belkhiri. (2012). ABL Regulation by AXL Promotes Cisplatin Resistance in Esophageal Cancer. Cancer Research. 73(1). 331–340. 69 indexed citations
17.
Sehdev, Vikas, Dunfa Peng, Mohammed Soutto, et al.. (2012). The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells. Molecular Cancer Therapeutics. 11(3). 763–774. 89 indexed citations
18.
Peng, Dunfa, Abbes Belkhiri, Rupesh Chaturvedi, et al.. (2011). Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut. 61(9). 1250–1260. 77 indexed citations
19.
Belkhiri, Abbes, Altaf A. Dar, Dunfa Peng, et al.. (2008). Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells. Clinical Cancer Research. 14(14). 4564–4571. 37 indexed citations
20.
Peng, Dunfa, Hiroyuki Sugihara, Ken‐ichi Mukaisho, Yasuhiro Tsubosa, & Takanori Hattori. (2003). Alterations of chromosomal copy number during progression of diffuse‐type gastric carcinomas: metaphase‐ and array‐based comparative genomic hybridization analyses of multiple samples from individual tumours. The Journal of Pathology. 201(3). 439–450. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026